AstraZeneca Earnings Beat Views; Company Says It's 'Returned To Growth' [Investor's Business Daily]
Merck & Company, Inc. (new) (MRK)
Last merck & company, inc. (new) earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.merck.com/home/default.aspx
Company Research
Source: Investors Business Daily
Related news 5:09 AM ET European stocks climbed at the open and U.S. equity futures advanced after the White House was said to weigh postponing... Merck Pops On Quarterly Beat As Keytruda Sales Jump Despite U.S. Lag Protein Degradation: Finally, A Way To Treat 'Undruggable' Diseases? AstraZeneca Sees IBD RS Rating Climb To 74 Pharma Stocks Topple After House Dems Launch Drug-Pricing Probe AstraZeneca Departures Continue As Medical Chief Bohen Exits This New Biotech Stock Is Popping — Will It Reclaim Its IPO Price? Stocks To Watch: AstraZeneca Sees Relative Strength Rating Jump To 91 Could This New Biotech IPO Score Big With A Cancer Vaccine? AstraZeneca earnings and revenue crushed fourth-quarter expectations, as the company said sales will accelerate in 2019. AstraZeneca stock surged Thursday on the news. Chief Executive Pascal Soriot confirmed that " AstraZeneca ( AZN ) has returned to growth." In the fourth quarter, revenue popped 14
Show less
Read more
Impact Snapshot
Event Time:
MRK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRK alerts
High impacting Merck & Company, Inc. (new) news events
Weekly update
A roundup of the hottest topics
MRK
News
- Merck (MRK) Rises Higher Than Market: Key Facts [Yahoo! Finance]Yahoo! Finance
- [Latest] Global Cancer Immunotherapy Market Size/Share Worth USD 314.4 Billion by 2032 at a 7.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) [Yahoo! Finance]Latest
- WebMD Health Services Announces Employee Engagement Solution Returns to Its Iconic Brand Name, TINYpulse [Yahoo! Finance]Yahoo! Finance
- How We Can Strengthen Vaccination Programs and Build Vaccine Confidence Together [Yahoo! Finance]Yahoo! Finance
- Global Montelukast Sodium Market Report 2024: A USD 2.24 Billion Market by 2034 at a CAGR of 15.7%, Driven by Rising Prevalence of Respiratory Diseases and Enhanced Drug Formulations [Yahoo! Finance]Yahoo! Finance
MRK
Earnings
- 2/1/24 - Beat
MRK
Sec Filings
- 3/28/24 - Form PX14A6G
- 3/19/24 - Form S-3ASR
- 3/19/24 - Form S-3ASR
- MRK's page on the SEC website